Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China.
CNS Neurosci Ther. 2012 Sep;18(9):773-80. doi: 10.1111/j.1755-5949.2012.00367.x.
AIMS: The aim of this study was to understand the association between clinical characteristics, medical management, and functional outcomes in Chinese patients with nontraumatic intracerebral hemorrhage (ICH). METHODS: The China National Stroke Registry (CNSR) was a prospective cohort study that included 132 Chinese hospitals. Logistic regression was used to determine the risk factors associated with poor outcomes at 3, 6, and 12 months, post-ICH onset. RESULTS: Three thousand two hundred fifty five ICH patients with follow-up information up to 1 year post-ICH were included in this study. 49.1%, 47.1%, and 46.0% of ICH patients had poor outcomes at 3, 6, and 12 months, respectively. Age, admission systolic blood pressure, admission Glasgow Coma Score, hematoma volume, withdrawal of support, and complication of gastrointestinal hemorrhage were associated with poor outcomes at 3 and 12 months. Stroke unit care was associated with good outcome at 3 months. Intensive care unit (ICU)/Neurology ICU care was associated with poor outcome at 3 months. CONCLUSION: This is the first report of long-term functional outcomes in ICH patients from mainland China. Our study elucidates the risk factors that may influence functional outcomes post-ICH and therefore facilitate the development of management strategies to improve ICH care in China.
目的:本研究旨在了解中国非创伤性颅内出血(ICH)患者的临床特征、医疗管理与功能结局之间的关联。
方法:中国国家卒中登记研究(CNSR)是一项前瞻性队列研究,纳入了 132 家中国医院。采用 logistic 回归分析确定与 ICH 发病后 3、6 和 12 个月时预后不良相关的风险因素。
结果:本研究共纳入了 3255 例 ICH 患者,随访信息至 ICH 发病后 1 年。ICH 患者在 3、6 和 12 个月时预后不良的比例分别为 49.1%、47.1%和 46.0%。年龄、入院收缩压、入院格拉斯哥昏迷评分、血肿量、支持治疗的撤除以及胃肠道出血并发症与 3 和 12 个月时的预后不良相关。卒中单元治疗与 3 个月时的良好结局相关。重症监护病房(ICU)/神经科 ICU 治疗与 3 个月时的不良结局相关。
结论:这是中国大陆首例关于 ICH 患者长期功能结局的报告。本研究阐明了可能影响 ICH 后功能结局的风险因素,从而有助于制定改善中国 ICH 治疗的管理策略。
J Stroke Cerebrovasc Dis. 2015-2
Cerebrovasc Dis. 2018
Int J Neurosci. 2017-7
Clin Neurol Neurosurg. 2015-7
Front Neurol. 2023-2-21
S Afr Fam Pract (2004). 2023-1-5
Lancet Neurol. 2012-1
CNS Neurosci Ther. 2011-10
Crit Care Med. 2010-2
Neurology. 2009-10-6
Lancet. 2009-5-9